https://biotechmorning.com/news/fomat-topography-health-largest-embedded-research-organization Biotech Morning en 2026-05-02T14:12:07.194Z The Biggest Clinical Trial Land Grab You Didn't See Coming https://biotechmorning.com/news/hemab-ipo-doubled-day-one-blood-disease-bet Biotech Morning en 2026-05-02T14:11:31.267Z Hemab's IPO Doubled on Day One. The Blood Disease Bet Wall Street Couldn't Resist. https://biotechmorning.com/news/seaport-therapeutics-ipo-neuropsychiatry-bet Biotech Morning en 2026-05-02T14:10:50.297Z The Brain Drug Startup That Convinced Wall Street to Bet $255M on Crazy https://biotechmorning.com/news/viking-obesity-drug-ligand-legal-dispute Biotech Morning en 2026-05-02T14:10:12.836Z Viking's Obesity Blockbuster Just Got a Legal Problem https://biotechmorning.com/news/summit-therapeutics-ivonescimab-trial-miss Biotech Morning en 2026-05-02T14:09:35.778Z Summit Therapeutics Was Supposed to Dethrone Keytruda. Then the Data Arrived. https://biotechmorning.com/news/fda-cber-prasad-exits-again Biotech Morning en 2026-05-02T14:08:54.198Z The FDA's Biologics Gatekeeper Just Walked Out (Again) https://biotechmorning.com/news/first-protac-fda-approval-vepdegestrant-breast-cancer Biotech Morning en 2026-05-02T14:08:14.162Z The First Drug That Eats a Cancer Protein Just Got FDA Approval https://biotechmorning.com/news/genomics-greywolf-autoimmune-gene-targets Biotech Morning en 2026-05-02T14:07:34.291Z Two Oxford Companies Think Your Genes Hold the Key to Autoimmune Disease https://biotechmorning.com/news/fda-slams-door-cheap-liraglutide-compounding Biotech Morning en 2026-05-02T14:06:55.767Z The FDA Just Slammed the Door on Cheap Liraglutide https://biotechmorning.com/news/hiv-drug-came-back-from-dead-idvynso Biotech Morning en 2026-05-01T14:13:04.133Z The HIV Drug That Came Back From the Dead https://biotechmorning.com/news/bms-terminates-zymeworks-bispecific-collaboration Biotech Morning en 2026-05-01T14:12:23.241Z BMS Just Ghosted a Decade-Old Partnership. Zymeworks Felt That. https://biotechmorning.com/news/astrazeneca-camizestrant-fda-panel-rejection Biotech Morning en 2026-05-01T14:11:43.744Z AstraZeneca Bet Big on Catching Cancer Before It Spreads. The FDA Wasn't Buying It. https://biotechmorning.com/news/jnj-cancels-car-t-program Biotech Morning en 2026-05-01T14:10:56.678Z J&J Just Torched $5 Billion in CAR-T Progress. Nobody Saw It Coming. https://biotechmorning.com/news/indivior-phase-2-failure-rd-layoffs Biotech Morning en 2026-05-01T14:10:09.469Z One Failed Trial Just Gutted Indivior's Entire R&D Operation https://biotechmorning.com/news/leo-pharma-replay-gene-therapy-skin Biotech Morning en 2026-05-01T14:09:32.430Z A $50M Bet That Herpes Could Fix Your Skin https://biotechmorning.com/news/glp1-revolution-ditched-the-needle Biotech Morning en 2026-05-01T14:08:51.340Z The GLP-1 Revolution Just Ditched the Needle https://biotechmorning.com/news/amgen-kills-two-programs-phase-2-failures Biotech Morning en 2026-05-01T14:08:11.498Z Amgen Just Killed Two Programs in One Week. Should Investors Worry?